Procedure
Plasma exchange (PE)
Plasma exchange (PE) is a medical procedure with 6 clinical trials. Currently 2 active trials ongoing. Historical success rate of 75.0%.
Total Trials
6
Max Phase
—
Type
PROCEDURE
Molecule
—
Success Metrics
Clinical Success Rate
75.0%
Based on 3 completed trials
Completion Rate
75%(3/4)
Active Trials
2(33%)
Results Posted
0%(0 trials)
Terminated
1(17%)
Phase Distribution
Ph not_applicable
2
33%
Ph phase_2
3
50%
Ph phase_4
1
17%
Phase Distribution
0
Early Stage
3
Mid Stage
1
Late Stage
Phase Distribution6 total trials
Phase 2Efficacy & side effects
3(50.0%)
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
2(33.3%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
75.0%
3 of 4 finished
Non-Completion Rate
25.0%
1 ended early
Currently Active
2
trials recruiting
Total Trials
6
all time
Status Distribution
Active(2)
Completed(3)
Terminated(1)
Detailed Status
Completed3
Active, not recruiting1
Recruiting1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
2
Success Rate
75.0%
Most Advanced
Phase 4
Trials by Phase
Phase 23 (50.0%)
Phase 41 (16.7%)
N/A2 (33.3%)
Trials by Status
active_not_recruiting117%
completed350%
recruiting117%
terminated117%
Recent Activity
2 active trials
Showing 5 of 6
completednot_applicable
Efficacy of IVIG Versus PLEX in Myasthenic Crisis in Syria.
NCT07532707
recruitingphase_4
Modified Zipper Therapy for AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder
NCT07420296
completedphase_2
A Trial of Caplacizumab in Japanese Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)
NCT04074187
completednot_applicable
CPI Combination Therapy for Autoimmune Encephalitis
NCT03542279
active_not_recruitingphase_2
A Clinical Trial With KJ103 in Anti-GBM Disease
NCT06607016
Clinical Trials (6)
Showing 6 of 6 trials
NCT07532707Not Applicable
Efficacy of IVIG Versus PLEX in Myasthenic Crisis in Syria.
NCT07420296Phase 4
Modified Zipper Therapy for AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder
NCT04074187Phase 2
A Trial of Caplacizumab in Japanese Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)
NCT03542279Not Applicable
CPI Combination Therapy for Autoimmune Encephalitis
NCT06607016Phase 2
A Clinical Trial With KJ103 in Anti-GBM Disease
NCT02647255Phase 2
Trial of Plasma Exchange for Severe Crescentic IgA Nephropathy
All 6 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 6